Clinical Trial

RAPA-Keloid Study of Keloid Regression

Study Description

RAPA-Keloid Study of Keloid Regression

1. To test whether topical rapamycin regresses established keloids in humans by measuring surface area and height changes in the scar over time (6 months) 2. To test safety of product and feasibility of conduct for future clinical trial

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Drug - Rapamycin 8% Ointment

A compounded ointment containing 8% rapamycin

Drug - Placebo

Petrolatum ointment placebo

Additional Information

Official Study Title

Effect of Topical Rapamycin Ointment on Keloid Regression: A Pilot Study in Human Subjects (RAPA-Keloid)

Clinical Trial ID

NCT04049552

ParticipAid ID

e9rwBa